{"id":3098,"date":"2022-03-21T10:20:43","date_gmt":"2022-03-21T00:20:43","guid":{"rendered":"\/eu-uk\/?p=3098"},"modified":"2022-03-21T10:20:43","modified_gmt":"2022-03-21T00:20:43","slug":"tga-approval-for-remplir","status":"publish","type":"post","link":"\/eu-uk\/blog\/2022\/03\/21\/tga-approval-for-remplir\/","title":{"rendered":"TGA Approval for Remplir\u2122"},"content":{"rendered":"

Orthocell\u2019s Remplir\u2122 device has gained Australian regulatory (Therapeutics Goods Administration) approval, representing a paradigm shift in product design and application for complex and often life-changing nerve repair procedures.<\/span><\/p>\n

Clinical studies have shown nerve repair with Remplir\u2122 consistently restores arm and hand function. The addressable market on home soil is significant too, with around 11,500 surgical repairs for peripheral nerves completed in Australia each year.\u00a0<\/span><\/p>\n

Remplir\u2122 is the first Australian-designed and manufactured medical device for nerve repair to gain regulatory (TGA)approval. A significant milestone.<\/span><\/p>\n

Click here to read today\u2019s ASX release.\u00a0<\/b><\/a><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Orthocell\u2019s Remplir\u2122 device has gained Australian regulatory (Therapeutics Goods Administration) approval.<\/p>\n","protected":false},"author":2,"featured_media":3099,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-3098","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t